Laura-Maria Krabbe
Has participated in:
-
Molecular markers in bladder cancer
-
Darolutamid (Nubeqa) : neue Therapieoption beim Hochrisiko-nmCRPC
-
Association of age with response to preoperative chemotherapy in patients with muscle-invasive bladder cancer
-
Artificial Intelligence Reveals Distinct Prognostic Subgroups of Muscle-Invasive Bladder Cancer on Histology Images